Amarin Corp Plc (AMRN)

[Birdbrain Ideas]

An announcement that Pfizer will pitch Vascepa to general practitioners in the U.S. and/or Europe would boost the share price.

Some upgrades from analysts would boost share price.

Positive results from one of the two drug trials would boost share price

The start of sales in any European country could boost share price.

A restoration of the lawsuit against Hikma by the Federal Circuit would boost share price.

A quarterly report that delivered profits of over $10 million would boost share price.

But, most of all, a report of meaningful income and sales in a place like England would boost share price.

A partnership of any kind with a big pharma would also boost share price.